title: [Atrial Fibrillation in Germany].
authors.affiliation: Institut für Empirische Gesundheitsökonomie, Burscheid.
authors.forename: Anna
authors.initials: A
authors.lastname: Spyra
authors.affiliation: Institut für Empirische Gesundheitsökonomie, Burscheid.
authors.forename: Dietmar
authors.initials: D
authors.lastname: Daniel
authors.affiliation: Abt. Cardiovascular / Hematology, Bayer HealthCare Deutschland, Leverkusen.
authors.forename: Inga-Marion
authors.initials: IM
authors.lastname: Thate-Waschke
authors.affiliation: Abt. Cardiovascular / Hematology, Bayer HealthCare Deutschland, Leverkusen.
authors.forename: Sabine
authors.initials: S
authors.lastname: Berghaus
authors.affiliation: Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie der Charité, Berlin.
authors.forename: Stefan N
authors.initials: SN
authors.lastname: Willich
authors.affiliation: Institut für Empirische Gesundheitsökonomie, Burscheid.
authors.forename: Reinhard
authors.initials: R
authors.lastname: Rychlik
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000191:economics* / Q000453:epidemiology; D015897:Comorbidity; D005260:Female; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data; D062489:Health Impact Assessment / Q000191:economics; D006801:Humans; D008297:Male; D015995:Prevalence; D020521:Stroke / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants